[Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis].
D000636:Aminosalicylic Acids / Q000494:pharmacology; D000818:Animals; D000995:Antitubercular Agents / Q000494:pharmacology*; D003523:Cycloserine / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000494:pharmacology; D007538:Isoniazid / Q000494:pharmacology; D007612:Kanamycin / Q000494:pharmacology; D008168:Lung / Q000382:microbiology; D051379:Mice; D008826:Microbial Sensitivity Tests; D009161:Mycobacterium / Q000187:drug effects / Q000302:isolation & purification; D009164:Mycobacterium Infections / Q000150:complications / Q000209:etiology*; D013154:Spleen / Q000382:microbiology; D013307:Streptomycin / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D013449:Sulfonamides; D007612:Kanamycin; D004977:Ethambutol; D003523:Cycloserine; D007538:Isoniazid; D013307:Streptomycin